Moreover, we discovered that furmonertinib effectively inhibits the drug efflux function of ABCB1 and ABCG2, leading to a substantial restoration of drug-induced apoptosis and reversal of MDR in cancer cells overexpressing these transporters. This evidence concerns the gene ABCG2 and cancer.